Researchers at Johns Hopkins Medicine have identified a critical role for the protein Cystathionine γ-lyase (CSE) in the production of trace amounts of hydrogen sulfide, a gas previously associated with neuroprotection. In genetically engineered mice lacking CSE, significant cognitive impairments emerged, mirroring symptoms of Alzheimer’s disease. These mice exhibited memory loss, oxidative stress, and compromised blood-brain barrier integrity, underscoring CSE’s importance in maintaining brain health.

The study, published in the Proceedings of the National Academy of Sciences, highlights how CSE influences neurogenesis and cognitive function. Mice deficient in CSE demonstrated a marked decline in spatial memory as they aged, while normal mice retained their cognitive abilities. The absence of CSE led to reduced neurotrophic signaling and structural damage in the hippocampus, a region essential for learning and memory. This aligns with previous findings that hydrogen sulfide can protect neurons, albeit in carefully regulated amounts due to its toxicity at higher concentrations.

Targeting CSE and its hydrogen sulfide production could represent a novel therapeutic strategy for Alzheimer’s disease. This research shifts the paradigm towards understanding the nuanced roles of gaseous signaling molecules in neurodegeneration, potentially accelerating drug development timelines aimed at enhancing cognitive function and slowing disease progression. As the prevalence of Alzheimer’s continues to rise, elucidating the mechanisms by which CSE operates may pave the way for innovative treatment pathways that leverage the protective properties of hydrogen sulfide without the associated risks of toxicity.

Source: sciencedaily.com